Improving Information to Caregivers Via Adaptation and Implementation of the HERMES Intervention (HERMESII)

Improving Information to Caregivers Via Adaptation and Implementation of the HERMES Intervention the Danish Health Care System

The HERMES intervention was developed in a Danish setting after a comprehensive investigation on caregivers' needs. The intervention consists of: 1) a systematic identification of the caregiver's unmet information needs and 2) a subsequent consultation with a nurse providing the lacking information. The evaluation carried out in a randomized trial at Herlev Hospital showed positive results. It reduced the unmet information needs and improved the caregivers' evaluation of the information from and communication with the health care professionals and the perception of being seen and acknowledged as a caregiver. However, although research projects may show a positive effect, this does not mean that the intervention will be easily implemented in the health care system. Nor does it guarantee that the intervention will show the expected results once implemented in a busy clinical routine.

Therefore, the present project will adapt the HERMES intervention to be implemented in Danish departments of oncology and haematology by (in the first part of the project):

1. Elucidating how the HERMES intervention is best implemented in the clinical setting according to the clinical staff.
2. Elucidating how the HERMES intervention is best implemented in the treatment and follow-up period according to the patients and their caregivers.
3. Developing a technological solution (an app) for the HERMES intervention in which the responses given by the caregivers will form the basis for a subsequent consultation with the health care staff.
4. Revising the HERMES intervention based on the outcomes of a-c.
5. Testing the revised HERMES intervention in a pilot study.

In the second part of the project, the revised HERMES intervention will be tested in a large scale trial with the purpose to:

1. Implement the revised HERMES intervention in the departments of oncology/haematology.
2. Test the effect of the revised HERMES intervention.
3. Evaluate the feasibility of the revised HERMES intervention in a large scale.
4. Elucidate the effectiveness and the feasibility of the intervention and assess possibilities and potential needs for further adaptation in order to secure the future applicability in the Danish Health Care System.

Thus, the overall aim is that by the end of the study, an evidence based and practical implementable method to (continous) use of the HERMES intervention in the Danish health care system is available.

Study Overview

• Status: Recruiting
• Conditions: Cancer
• Intervention / Treatment: Behavioral: HERMES

• Study Type: Interventional
• Enrollment (Anticipated): 1500
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Mathilde Adsersen, PhD; Phone Number: 004538635131; Email: mathilde.adsersen@regionh.dk

Study Locations

• Denmark
  • Aalborg, Denmark
    • Recruiting
    • Aalborg Universitetshospital
    • Contact: Charlotte B Rotboel, MD; Email: c.rotboel@rn.dk
  • Copenhagen, Denmark, 2100
    • Recruiting
    • Rigshospitalet
    • Contact: Ulla B Tange, MD; Email: ulla.brix.tange@regionh.dk
  • Herlev, Denmark
    • Recruiting
    • Herlev Hospital
    • Contact: Katrine R Jervad, Nurse; Email: katrine.roshani.jervad@regionh.dk
  • Herning, Denmark
    • Recruiting
    • Hospitalsenheden Vest
    • Contact: Hanne Linnet, MD; Email: hannsind@rm.dk
  • Naestved, Denmark
    • Recruiting
    • Naestved Sygehus
    • Contact: Elizabeth Rosted, PhD, Nurse; Email: eros@regionsjaelland.dk
  • Roskilde, Denmark
    • Recruiting
    • Roskilde Universitetshospital
    • Contact: Elizabeth Rosted, PhD, Nurse; Email: eros@regionsjaelland.dk
  • Soenderborg, Denmark
    • Recruiting
    • Sygehus Soenderjylland
    • Contact: Joan Lassen, Nurse; Email: joan.lassen@rsyd.dk
  • Vejle, Denmark
    • Recruiting
    • Vejle Sygehus
    • Contact: Hroenn Thorn, Nurse; Email: hronn.thorn@rsyd.dk

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Adult (18+ years)
• Primary caregiver (defined as the lay person (partner, family member, friend, etc) most involved in the patient's disease course. The primary caregiver is appointed by the patient)
• Caregiver of an adult cancer patient starting up a treatment course in an oncological department
• Written informed consent to participation

Exclusion Criteria:

• Caregivers not able to read and understand Danish
• Caregivers with no or minimal contact to the oncological department

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Health Services Research
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
No Intervention: Control; ('Standard' care). No intervention offered.
Experimental: Intervention; ('Standard' care +) The 'Herlev Hospital Empowerment of Relatives through More and Earlier information Supply' (HERMES) intervention.	Behavioral: HERMES; Via an app, the caregiver answers 14 questions about his/her need for (more) information. The caregiver presents his/her answers (i.e., need for information) to the health care professionals (HCPs), and the HCPs provide the caregiver with the lacking information.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Quality of information from and communication with health care professionals	Measured by the subscale 'Problems with the quality of information from and communication with health care professionals' in the Cancer Caregiving Tasks, Consequences and Needs Questionnaire (CaTCoN). Subscale score range: 0-100. A higher score represents a worse outcome, i.e. more problems with the quality of information from and communication with health care professionals.	Change from baseline (enrollment) to 3 months follow-up

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Quality of information from and communication with health care professionals	Measured by the subscale 'Problems with the quality of information from and communication with health care professionals' in the Cancer Caregiving Tasks, Consequences and Needs Questionnaire (CaTCoN). Subscale score range: 0-100. A higher score represents a worse outcome, i.e. more problems with the quality of information from and communication with health care professionals.	Change from baseline (enrollment) to 6 months follow-up
Amount of information from health care professionals	Measured by (a revised version of) the subscale 'Lack of information from health care professionals' in the Cancer Caregiving Tasks, Consequences and Needs Questionnaire (CaTCoN). Subscale score range: 0-100. A higher score represents a worse outcome, i.e. more lack of information from health care professionals	Change from baseline (enrollment) to 3 months follow-up
Amount of information from health care professionals	Measured by (a revised version of) the subscale 'Lack of information from health care professionals' in the Cancer Caregiving Tasks, Consequences and Needs Questionnaire (CaTCoN). Subscale score range: 0-100. A higher score represents a worse outcome, i.e. more lack of information from health care professionals	Change from baseline (enrollment) to 6 months follow-up
Attention from health care professionals	Measured by the subscale 'Lack of attention from health care professionals on the caregivers' wellbeing' in the Cancer Caregiving Tasks, Consequences and Needs Questionnaire (CaTCoN). Subscale score range: 0-100. A higher score represents a worse outcome, i.e. more lack of attention from health care professionals	Change from baseline (enrollment) to 3 months follow-up
Attention from health care professionals	Measured by the subscale 'Lack of attention from health care professionals on the caregivers' wellbeing' in the Cancer Caregiving Tasks, Consequences and Needs Questionnaire (CaTCoN). Subscale score range: 0-100. A higher score represents a worse outcome, i.e. more lack of attention from health care professionals	Change from baseline (enrollment) to 6 months follow-up
Caregiver involvement	Measured by item 12 in the Caregiving Tasks, Consequences and Needs Questionnaire (CaTCoN). Item score range: 0-100. A higher score represents a worse outcome, i.e. more caregiver dissatisfaction with involvement	Change from baseline (enrollment) to 3 months follow-up
Caregiver involvement	Measured by item 12 in the Caregiving Tasks, Consequences and Needs Questionnaire (CaTCoN). Item score range: 0-100. A higher score represents a worse outcome, i.e. more caregiver dissatisfaction with involvement	Change from baseline (enrollment) to 6 months follow-up
Emotional functioning	Measured by the European Organisation for Research and Treatment of Cancer (EORTC) Emotional Functioning 10 scale (EORTC EF10). Subscale score range: 0-100. A higher score represents a worse outcome, i.e. worse emotional functioning	Change from baseline (enrollment) to 3 months follow-up
Emotional functioning	Measured by the EORTC Emotional Functioning 10 scale (EORTC EF10). Subscale score range: 0-100. A higher score represents a worse outcome, i.e. worse emotional functioning	Change from baseline (enrollment) to 6 months follow-up
Positive emotional functioning	Measured by a scale of five positively formulated items concerning emotional functioning which were excluded from the EORTC Computerized Adaptive Test (CAT) emotional functioning bank during the development of the item bank. Subscale score range: 0-100. A higher score represents a better outcome, i.e. more positive emotional functioning	Change from baseline (enrollment) to 3 months follow-up
Positive emotional functioning	Measured by a scale of five positively formulated items concerning emotional functioning which were excluded from the EORTC Computerized Adaptive Test (CAT) emotional functioning bank during the development of the item bank. Subscale score range: 0-100. A higher score represents a better outcome, i.e. more positive emotional functioning	Change from baseline (enrollment) to 6 months follow-up

Collaborators and Investigators

• Sponsor: Bispebjerg Hospital
• Collaborators: Herlev Gentofte University Hospital, Denmark; Rigshospitalet, University of Copenhagen, Denmark; South Jutland Hospital, Denmark
• Investigators: Principal Investigator: Mogens Groenvold, PhD DMSc, Bispebjerg and Frederiksberg Hospital, University of Copenhagen

Study record dates

Study Major Dates

• Study Start (Actual): February 1, 2021
• Primary Completion (Anticipated): April 15, 2022
• Study Completion (Anticipated): July 15, 2022

Study Registration Dates

• First Submitted: June 16, 2020
• First Submitted That Met QC Criteria: June 16, 2020
• First Posted (Actual): June 18, 2020

Study Record Updates

• Last Update Posted (Actual): March 2, 2022
• Last Update Submitted That Met QC Criteria: March 1, 2022
• Last Verified: March 1, 2022

More Information

Terms related to this study

• Keywords: Cancer; Intervention; Information; Informal caregivers; Stepped wedge cluster randomized controlled trial
• Other Study ID Numbers: R210-A12901

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No